🇺🇸 FDA
Patent

US 9877988

Method of treating lysosomal storage diseases using nucleases and a transgene

granted A61KA61K35/28A61K38/46

Quick answer

US patent 9877988 (Method of treating lysosomal storage diseases using nucleases and a transgene) held by Sangamo Therapeutics, Inc. expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K35/28, A61K38/46, A61K38/465, A61K48/00